116
12
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3160 |
HUHS015
|
Others | Others |
HUHS015 是高效的PCA-1/ALKBH3抑制剂。它对 PCA-1 作用的IC50值为 0.67 μM。 | |||
T8995 |
NCGC00262650
|
Others; Src | Angiogenesis; Others; Tyrosine Kinase/Adaptors |
NCGC00262650 是 AMA1-RON2 相互作用和 c-Src 酪氨酸激酶活性的抑制剂。 | |||
T2051 |
SKLB4771
FLT3-IN-1,FLT3-IN-1 |
FLT | Angiogenesis; Tyrosine Kinase/Adaptors |
SKLB4771 (FLT3-IN-1) 是一种新型的、高效的 Flt3 抑制剂 (IC50:10nM)。 | |||
T9027 |
CA-4948
Emavusertib |
IRAK; FLT | Angiogenesis; Immunology/Inflammation; NF-κB; Tyrosine Kinase/Adaptors |
CA-4948 (Emavusertib) 是一种IRAK4抑制剂,也是一种FLT3抑制剂,具有抗肿瘤作用。 | |||
T2514 |
Linifanib
利尼伐尼,ABT-869,RG3635,AL-39324 |
Apoptosis; c-Fms; VEGFR; FLT; CSF-1R; PDGFR; c-Kit; Autophagy | Angiogenesis; Apoptosis; Autophagy; Tyrosine Kinase/Adaptors |
Linifanib (AL-39324) 是一种高效口服的VEGFR 和PDGFR 家族多靶点抑制剂,具有显著的抗肿瘤活性。它对无关 RTKs、可溶性酪氨酸激酶或丝氨酸/苏氨酸激酶的活性要低得多。它是特异性 miR-10b 抑制剂,阻断miR-10b 的生物合成。 | |||
T6289 |
Dovitinib
TKI258,多韦替尼,CHIR-258,度维替尼 |
VEGFR; FGFR; FLT; PDGFR; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
Dovitinib (CHIR-258) 是一种口服有效的、多靶点的酪氨酸激酶 (RTK) 抑制剂,具有抗肿瘤作用。 | |||
T5164 |
Cabozantinib hydrochloride
XL184,Cabozantinib hydrochloride (849217-68-1(free base)),BMS-907351,盐酸卡博替尼 |
VEGFR; FLT; c-Met/HGFR; TAM Receptor; c-Kit; ROR | Angiogenesis; Metabolism; Tyrosine Kinase/Adaptors |
Cabozantinib hydrochloride (XL184) 是一种有效的泛酪氨酸激酶抑制剂,可抑制 VEGFR2、c-Met、Kit、Axl 和 Flt4(IC50:0.035、1.3、4.6、7 和 6 nM)。 | |||
T6028 |
PF 477736
PF 00477736,PF-477736,PF-736,PF-00477736,PF477736 |
c-Fms; VEGFR; FGFR; FLT; c-RET; Chk; CDK; Src; Aurora Kinase | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors |
PF 477736 (PF-736,PF-00477736) 是一种特异性、有效且具有 ATP 竞争性的 Chk1 抑制剂,Ki 值为0.49 nM。它也是Chk2抑制剂,Ki 值为 47 nM。它还抑制VEGFR2、Fms、Yes、Aurora-A、FGFR3、Flt3和Ret。 | |||
T4349 |
Sitravatinib
MG516,MGCD516 |
Discoidin Domain Receptor (DDR); VEGFR; FLT; Trk receptor; TAM Receptor; c-Kit; Ephrin Receptor | Angiogenesis; Tyrosine Kinase/Adaptors |
Sitravatinib (MGCD516) 是一种有口服活性的受体酪氨酸激酶抑制剂。它单独使用即具有有效的抗肿瘤功效,且通过促进抗肿瘤免疫微环境增强了 PD-1 阻断的活性。 | |||
T3977 |
Lifitegrast
SHP-606,SAR 1118,立他司特,利非司特 |
Integrin | Cytoskeletal Signaling |
Lifitegrast (SAR 1118) 是一种整合素淋巴细胞功能相关抗原 1 拮抗剂, 抑制 Jurkat T 细胞附着于ICAM-1的IC50为 2.98 nM。 | |||
TP1493L1 |
PSA1 141-150 acetate
PSA1 141-150 acetate(160215-60-1 free base) |
Others | Others |
PSA1 141-150 acetate 用于癌症实验的免疫治疗,它是一种前列腺特异性抗原 1 肽。 | |||
T21781 |
A-286982
|
Integrin | Cytoskeletal Signaling |
A 286982是高效的LFA-1/ICAM-1相互作用变构抑制剂,在LFA-1/ICAM-1结合和LFA-1介导的细胞粘附实验中,其IC50分别为44和35 nM。 | |||
T14676 |
BMS-688521
|
Integrin | Cytoskeletal Signaling |
BMS-688521 是一种具有口服活性和高效性的 LFA-1/ICAM 相互作用抑制剂,是白细胞功能相关抗原-1 (LFA-1) 的小分子拮抗剂,具有潜在的抗炎活性。 | |||
T12783 |
RWJ 50271
|
Integrin | Cytoskeletal Signaling |
RWJ 50271 是具有口服活性的选择性LFA-1/ICAM-1相互作用抑制剂,抑制 LFA-1/ICAM-1 介导的细胞粘附,在细胞HL60中的IC50值为 5.0 μM。 | |||
T14333 |
Asoxime dichloride
Tert-Butyl2-(2-hydroxyethyl)-1-pyrrolidinecarboxylate,Asoxime (dichloride),HI-6 |
AChR | Neuroscience |
Asoxime dichloride (Tert-Butyl2-(2-hydroxyethyl)-1-pyrrolidinecarboxylate) 是乙酰胆碱受体 (AChRs) 拮抗剂,包括烟碱受体,α7 乙酰胆碱受体。Asoxime dichloride 参与调节免疫应答。Asoxime dichloride 可作为抗原使用,改善神经系统的免疫效果。 | |||
T35719 |
T2AA
T2AA,4-[4-[(2S)-2-amino-3-hydroxypropyl]-2,6-diiodophenoxy]phenol,ZINC95605533 |
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
T2AA (4-[4-[(2S)-2-amino-3-hydroxypropyl]-2,6-diiodophenoxy]phenol) 是一种增殖细胞核抗原 (PCNA) 抑制剂,对 PCNA/PIP-box 肽相互作用的 IC50 为 1 μM。 T2AA 通过停止 DNA 复制叉和抑制 PCNA 与 DNA 聚合酶 δ 的相互作用来引起 DNA 复制压力并抑制癌细胞生长。 | |||
T63790 |
Cbl-b-IN-3
|
E1/E2/E3 Enzyme | Ubiquitination |
Cbl-b-IN-3是一种有效的casitas b 系淋巴瘤原癌基因-b (Cbl-b)抑制剂(ic50 < 1 nM)。Cbl-b 是一种环型E3泛素蛋白连接酶,与T 淋巴细胞激活阈值的设定有关。Cbl-b 以不依赖于蛋白水解的方式负调控p85,通过其E3泛素连接酶活性,参与了p85向CD28和T 细胞抗原受体ζ的募集,抑制PI3K 抑制了Cblb-/- t 细胞活化的增强。 | |||
T80552 |
Prostate Specific Antigen Substrate
|
||
Prostate Specific Antigen Substrate为前列腺特异性抗原(PSA)的荧光底物,专用于检测PSA的酶活性。 | |||
T14558 |
BI-1950
|
Integrin | Cytoskeletal Signaling |
BI-1950 is a highly potent lymphocyte function associated antigen-1 (LFA-1) inhibitor and the LFA-1 is an essential component in normal immune system function and a target for drug discovery[1]. | |||
T81883 |
MAGE-3 Antigen (167-176) (human)
|
||
MAGE-3 Antigen (167-176) (human) 是一个由 MAGE-A3 编码并与 HLA-B44 抗原结合的人类抗原决定簇,包含8个氨基酸的多肽序列。 | |||
TP1493 |
PSA1 (141-150)
PSA1 141-150 |
||
This Prostate Specific Antigen 1 peptide was used in the immunotherapy of cancer experiments. | |||
T69203 |
HMR1031
|
||
HMR1031 is a potent and specific integrin α4ß1 or very late antigen 4 (VLA-4) receptor antagonist which binds to vascular cell adhesion molecule-1 (VCAM-1) and fibronectin. | |||
T76532 |
HBV Seq1 aa:93-100
|
||
HBVSeq1 aa:93-100 是乙型肝炎病毒 (HBV) 核心抗原 93-100 肽片段。 | |||
T3977L |
Lifitegrast sodium
SAR-1118-023,SAR1118-023,SAR 1118-023,Xiidra |
||
Lifitegrast sodium (SAR-1118) is an LFA-1 antagonist for the therapy of vascular complications of the eye. It inhibits T cell-mediated inflammation by blocking the binding of two cell surface proteins (lymphocyte function-associated antigen 1 and intercel | |||
T62921 | EBNA1-IN-SC7 | ||
EBNA1-IN-SC7 (compound SC7) 是一种 Epstein-Barr nuclear antigen 1 (EBNA1) 的选择性抑制剂,能够干扰 EBNA1-DNA 结合活性 (IC50: 23 μM)。EBNA1-IN-SC7 能够用于研究 EBV (Epstein-Barr virus) 相关癌症。 | |||
T82340 |
Ganglioside GM2
|
||
Ganglioside GM2为人类肿瘤抗原(OFA-I-1),亦是泰-萨克斯病中主要的溶酶体贮存化合物。 | |||
T76534 |
HBV Seq1 aa:18-27
|
||
HBVSeq1 aa:18-27 是乙型肝炎病毒 (HBV) 核心抗原 18-27 肽片段。 | |||
T82449 |
Eramkafusp Alfa
|
||
Eramkafusp Alfa为针对小鼠B淋巴细胞上CD20 (MS4A1) 抗原的人源化IgG1单克隆抗体。 | |||
T80966 |
Topsalysin
PRX-302 |
||
Topsalysin为PSA激活的前体蛋白质,同时是与人前列腺特异性抗原融合的孔隙形成蛋白(合成原气溶素)。研究显示Topsalysin能够抑制小鼠模型中的肿瘤生长。 | |||
T81252 |
RTQLLWTPAAPTAMA TFA
|
||
RTQLLWTPAAPTAMA TFA为肽类抗原,用于免疫应答中的药物传递。 | |||
T64475 |
FMOC-L-THR
|
||
FMOC-L-THR (AZP-531) is an analogue of unacylated ghrelin designed to improve glycaemic control and reduce weight. The O-glycosidic linkage and the O-acetyl protection in this building block is stable to both piperidine and TFA, making it completely compatible with standard protocols in Fmoc solid phase peptide synthesis. The Tn antigen is a tumor-associated carbohydrate antigen that is not normally expressed in peripheral tissues or blood cells. Expression of this antigen, which is found in a m... | |||
T78285 |
Sofituzumab
MMUC 1206A |
||
Sofituzumab(MMUC 1206A)是一款针对MUC16的重组人源化V-kappa型单克隆抗体。 | |||
T80209 |
Human membrane-bound PD-L1 polypeptide
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
Human membrane-bound PD-L1 polypeptide 作为抗原,可诱导生成相应的PD-L1抗体。 | |||
T78298 |
Alefacept
LFA 3TIP,Human LFA 3IgG fusion protein,BG 9273 |
||
Alefacept (BG 9273)为一种人类淋巴细胞功能相关抗原3/免疫球蛋白1融合蛋白,主要在慢性斑块状银屑病研究中使用。 | |||
T81627 |
Oberotatug
|
||
Oberotatug为针对淋巴细胞抗原LY75的人源化IgG1κ单克隆抗体。 | |||
T76966 | Ublituximab | ||
Ublituximab (LFB-R603; TG-1101; TGTX-1101) 为针对CD20抗原特异表位的第一代嵌合型单克隆抗体,展现出抗癌活性。 | |||
TP1268 |
CEF19, Epstein-Barr Virus latent NA-3A (458-466)
CEF19,Epstein-Barr Virus latent NA-3A 458-466 |
||
CEF19, Epstein-Barr Virus latent NA-3A (458-466) is a single peptide epitope, YPLHEQHGM, representing residues 458-466 of the type 1 Epstein-Barr Virus (EBV) nuclear antigen 3A protein (B95.8 strain). | |||
T35884 |
Sialyl-Lewis X
|
||
Sialyl-Lewis X (sLeX), a sialylated fucosylated tetrasaccharide and endogenous antigen, serves as a high-affinity ligand for selectins (E-, P-, and L-selectin)[1]. It interacts with ELAM-1 and CD62, consequently inhibiting CD62-mediated neutrophil recruitment to inflammation sites[2]. | |||
T81103 |
SSA antigenic peptide
|
||
SSA antigenic peptide为Sjögren综合征相关抗原A(SSA)的成分,具有免疫活性的短肽链。 | |||
T38420 |
GCPII-IN-1
|
||
GCPII-IN-1 is a potent inhibitor scaffold targeting glutamate carboxypeptidase II (GCPII), also known as prostate-specific membrane antigen (PSMA). It exhibits a high affinity for GCPII, with a binding affinity (K i ) of 44.3 nanomolar (nM). | |||
T80875 |
Vatelizumab
GBR500 |
||
Vatelizumab (GBR500)为靶向VLA-2(极晚期抗原2)α2亚基(CD49b)的单克隆抗体,适用于多发性硬化症研究。 | |||
T76835 | Tositumomab | ||
Tositumomab 是一种靶向CD20抗原的小鼠IgG2a lambda 单克隆抗体,CD20抗原存在于正常和恶性B 淋巴细胞表面。 | |||
T76529 |
HBV Seq2 aa:28-39
|
||
HBVSeq2 aa:28-39 是一种 HBsAg 肽,可与主要组织相容性复合体 (MHC) I 类分子结合。 | |||
T76015 |
HPV16 E7 (86-93) (TFA)
|
||
HPV16 E7 (86-93) TFA,一种HLA-A2.1限制的HPV16 E7衍生肽,在宫颈癌中显示出免疫原性。 | |||
T78121 |
SSM3 tetraTFA hydrate
|
Others | Others |
SSM3 tetraTFA hydrate为有效的furin抑制剂,具有54 nM的EC50和12 nM的Ki。该化合物可有效阻断furin依赖的炭疽毒素保护antigen-83在细胞表面的处理。 | |||
T79707 |
Cholicamideβ
|
Necroptosis | Apoptosis |
Cholicamideβ(compound 6)为自组装小分子癌症疫苗佐剂,能够形成细胞毒性低的病毒样颗粒。该化合物与肽抗原结合,可增强树突状细胞的抗原呈递能力,并激活抗原特异性T细胞反应。Cholicamideβ还能引发细胞凋亡(apoptosis)和坏死(necrosis)。 | |||
T76528 |
Hepatitis b virus pre-s region (120-145)
|
||
Hepatitis b virus pre-s region (120-145) 是一种 preS2 肽,可抑制单链 Fv 片段 (scFv) 或IgG 与 r-HBsAg 的结合。 | |||
T82179 |
HOXB7 8–25
MDM2 32-46 |
||
HOXB7 8–25 (MDM2 32-46)为来源于MDM2的肽段,能够特异性诱导抗原和激活肿瘤反应性的CD4+ T细胞。 | |||
T77103 | Nurulimab | ||
Nurulimab (BCD-145) 是一种抗细胞毒性 T 淋巴细胞抗原 4 (抗 CTLA-4) 人源化单克隆抗体。Nurulimab 可用于黑色素瘤的研究。 | |||
T62433 | (5S,8R)-HBV-IN-10 | ||
(5S,8R)-HBV-IN-10 是一种 compound 6 (WO2021204258A1) 的异构体。其中 Compound 6 是一种乙型肝炎表面抗原 (HBsAg) 的有效抑制剂 (0.1 μM< EC50≤1 μM)。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T79975 |
Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside
|
HBV | Microbiology/Virology |
Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside(化合物1)是一种具有抗HBV活性的木脂素类化合物。该化合物对HBV表面抗原(HBsAg)的IC50为0.58 mM,而对HBV e抗原(HBeAg)的IC50 > 2.4 mM。其可从八角茴香中提取分离。 | |||
T81813 |
Methyl lucidenate Q
|
||
Methyl lucidenate Q,一种灵芝甲酯,展现了显著的抑制作用于EBV-EA诱导活性。 | |||
T14368 |
Azadirachtin B
|
Others | Others |
Azadirachtin B, a limonoid derived from the seed kernels of Azadirachta indica, exhibits a broad spectrum of biochemical activities, including insecticidal, nematocidal, anticancer, anti-inflammatory, antiviral, and osteogenic effects. It is effective against the Epstein-Barr virus early antigen (EBV-EA), enhances alkaline phosphatase (ALP) activity, and promotes osteoblast differentiation[1][2][3]. | |||
T79976 |
Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside
|
HBV | Microbiology/Virology |
Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside 作为一种抗HBV剂,在Hep G2.2.15细胞系上能够抑制HBsAg和HBeAg的分泌,其IC50值分别约为1.67 mM和>2.15 mM。 | |||
T82855 |
Blood group A pentasaccharide
A-Pentasaccharide |
||
A-Pentasaccharide 是一种尿液中的寡糖,具有抑制抗 A 抗体与 A 型血物质结合的功能。 | |||
T38838 |
QS-21
Stimulon,QS-21 |
||
QS-21, an immunostimulatory saponin, is a powerful vaccine adjuvant that stimulates both Th2 humoral and Th1 cell-mediated immune responses by interacting with antigen presenting cells (APCs) and T cells. Additionally, QS-21 activates the NLRP3 inflammasome, leading to the release of cytokines IL-1β and IL-18, which are dependent on caspase-1. | |||
T82856 |
Blood group A antigen tetraose type 5
A-Tetrasaccharide |
||
Blood group A antigen tetraose type 5 (A-Tetrasaccharide) 是特定于A型血的四糖,具有阻止抗-A抗体与A型血物质结合的能力。该化合物可通过北极熊乳样本纯化获得。 | |||
TN3736 | Cycloart-25-ene-3,24-diol | Others | Others |
(24R)-Cycloart-25-ene-3beta,24-diol may be an anti-tumor promoter, it exhibits inhibitory effects on both Epstein-Barr virus early antigen (EBV-EA) and (+/-)-(E)-methtyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3- hexemide (NOR 1) activation. | |||
T79977 |
Maceneolignan A
|
||
Maceneolignan A,一种可从肉豆蔻(肉豆蔻科)假种皮分离的天然产品,有能力抑制RBL-2H3细胞内β-己糖胺酶释放,其IC50值为48.4 μM。同样,Maceneolignan A对抗原激活的RBL-2H3细胞中TNF-α释放的抑制作用,其IC50为63.7 μM。 | |||
T75567 | Cabenoside D | ||
Cabenoside D(化合物 8)是从苔藓根的甲醇提取物中分离的一种三萜苷,显示出对12-O-十四烷酰基激素-13-乙酸酯(TPA)诱导的小鼠炎症的抗炎活性,并能抑制TPA促使的Epstein-Barr病毒(EBV)早期抗原(EBV-EA)激活。 | |||
T75566 | 11-Oxomogroside II A1 | ||
11-Oxomogroside II A1(化合物 7)是一种从罗汉果乙醇提取物中分离的氧化葫芦苷,对12-O-十四烷酰基激素-13-乙酸酯(TPA)诱导的Epstein-Barr病毒(EBV)早期抗原(EBV-EA)活化具有抑制效果,并对一氧化氮(NO)供体(+/-)-(E)-甲基-2-[(E)羟基亚氨基]-5-硝基-6-甲氧基-3-己酰胺(NOR 1)的活化也展示出轻微的抑制作用。 | |||
T37272 |
9(S),12(S),13(S)-TriHOME
|
||
9(S),12(S),13(S)-TriHOME is a linoleic acid-derived oxylipin that has diverse biological activities.1,2,3,4It has been found in various plants and is produced in human eosinophils in a 15-lipoxygenase-dependent, soluble epoxide hydrolase-independent manner.1,59(S),12(S)13(S)-TriHOME inhibits antigen-induced β-hexosaminidase release from RBL-2H3 mast cells (IC50= 28.7 μg/ml).2It inhibits LPS-induced nitric oxide (NO) production in BV-2 microglia (IC50= 40.95 μM).3In vivo, 9(S),12(S),13(S)-TriHOME... |